Harbin Medisan Pharmaceutical Co.,Ltd.’s Net Profit Rose 208.7% in First Three Quarters of 2023

Harbin Medisan Pharmaceutical Co.,Ltd. (哈尔滨三联药业股份有限公司) (002900.SZ) reported a net profit of 57.5 million yuan in the first three quarters of 2023, up 208.7% year-on-year.

Meanwhile, the company posted 922.5 million yuan in revenue, up 21.1% year-on-year.

At the end of the reporting period, it had 3.4 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 37.9%.